Evogene (EVGN) Scheduled to Post Earnings on Thursday

Evogene (NASDAQ:EVGN) is set to post its quarterly earnings results before the market opens on Thursday, November 21st. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Evogene (NASDAQ:EVGN) last posted its quarterly earnings data on Thursday, August 22nd. The biotechnology company reported ($1.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.94). Evogene had a negative net margin of 210.26% and a negative return on equity of 72.33%. The firm had revenue of $0.91 million during the quarter.

Evogene Stock Performance

Shares of NASDAQ EVGN opened at $1.68 on Tuesday. The firm has a market cap of $9.02 million, a price-to-earnings ratio of -0.44 and a beta of 1.43. Evogene has a 1 year low of $1.66 and a 1 year high of $10.40. The stock’s 50-day simple moving average is $2.49 and its 200-day simple moving average is $4.59.

Analyst Upgrades and Downgrades

EVGN has been the topic of a number of recent analyst reports. StockNews.com assumed coverage on Evogene in a research report on Monday. They issued a “sell” rating on the stock. Lake Street Capital dropped their price target on shares of Evogene from $30.00 to $12.00 and set a “buy” rating for the company in a research note on Friday, August 23rd.

Evogene Company Profile

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.